Do I need a CGM if my HbA1c and fasting glucose are normal?

For most metabolically healthy adults, no. The value of a CGM in this population is mostly diagnostic curiosity and behavior motivation, not clinical decision-making. A short 2-4 week window for motivation is reasonable; continuous use is rarely necessary.

How accurate are the over-the-counter CGMs?

The OTC sensors (Stelo, Lingo) use the same underlying technology as prescription CGMs. Accuracy is comparable. The OTC versions sometimes have fewer features and may not support insulin-pump integration.

Can I use a CGM to design a personalized diet?

To some extent, yes. CGMs reveal which foods spike your glucose more than others. The complication is that the same food affects different people differently, and that day-to-day variation (sleep, stress, training) affects the response. A CGM can guide reasonable adjustments; it should not be the only data point.

Are post-meal glucose spikes dangerous in non-diabetic adults?

Modest post-meal spikes (under 140) are normal and not concerning. Larger spikes (over 180) or prolonged elevations may indicate early insulin resistance and are worth addressing. The threshold for clinical concern is debated.

Does insurance cover CGM for non-diabetic use?

Usually no. Coverage is generally limited to diabetes, sometimes prediabetes. Some plans are expanding coverage for non-diabetic metabolic health use; this is changing.

How does Fishtown Medicine decide when to recommend a CGM?

We use a CGM when the dynamic glucose data is likely to either change a clinical decision or drive behavior change that other data has not driven. For a patient with PCOS and a strong family history of diabetes, the data often changes treatment. For a metabolically healthy 30-year-old who is curious, we sometimes recommend a short window for motivation. For a patient with disordered eating history, we usually avoid CGMs.

What is the relationship between glucose variability and longevity?

Higher glucose variability correlates with worse cardiovascular and metabolic outcomes in some studies. The causal direction is not always clear. For the average non-diabetic adult, reducing extreme post-prandial spikes through food choices and meal timing is reasonable; chasing minute-to-minute stability is probably overkill.

How does Philadelphia's healthcare landscape affect CGM access?

CGM access in Philadelphia is good through major pharmacies. The bottleneck is usually not access but interpretation: most primary care visits do not have the time to walk through 14 days of CGM data and design a meaningful response. A direct primary care practice with time for that conversation makes CGMs much more useful.

What is the long-arc plan for someone using a CGM?

A 2-4 week diagnostic window, a structured review, a specific behavior change (timing, food choices, meal sequencing), and a re-check at 3-6 months with another short CGM window if useful. For most patients, this beats continuous use both in cost and in actionability.

Do I need a CGM if my HbA1c and fasting glucose are normal?

For most metabolically healthy adults, no. The value of a CGM in this population is mostly diagnostic curiosity and behavior motivation, not clinical decision-making. A short 2-4 week window for motivation is reasonable; continuous use is rarely necessary.

How accurate are the over-the-counter CGMs?

The OTC sensors (Stelo, Lingo) use the same underlying technology as prescription CGMs. Accuracy is comparable. The OTC versions sometimes have fewer features and may not support insulin-pump integration.

Can I use a CGM to design a personalized diet?

To some extent, yes. CGMs reveal which foods spike your glucose more than others. The complication is that the same food affects different people differently, and that day-to-day variation (sleep, stress, training) affects the response. A CGM can guide reasonable adjustments; it should not be the only data point.

Are post-meal glucose spikes dangerous in non-diabetic adults?

Modest post-meal spikes (under 140) are normal and not concerning. Larger spikes (over 180) or prolonged elevations may indicate early insulin resistance and are worth addressing. The threshold for clinical concern is debated.

Does insurance cover CGM for non-diabetic use?

Usually no. Coverage is generally limited to diabetes, sometimes prediabetes. Some plans are expanding coverage for non-diabetic metabolic health use; this is changing.

How does Fishtown Medicine decide when to recommend a CGM?

We use a CGM when the dynamic glucose data is likely to either change a clinical decision or drive behavior change that other data has not driven. For a patient with PCOS and a strong family history of diabetes, the data often changes treatment. For a metabolically healthy 30-year-old who is curious, we sometimes recommend a short window for motivation. For a patient with disordered eating history, we usually avoid CGMs.

What is the relationship between glucose variability and longevity?

Higher glucose variability correlates with worse cardiovascular and metabolic outcomes in some studies. The causal direction is not always clear. For the average non-diabetic adult, reducing extreme post-prandial spikes through food choices and meal timing is reasonable; chasing minute-to-minute stability is probably overkill.

How does Philadelphia's healthcare landscape affect CGM access?

CGM access in Philadelphia is good through major pharmacies. The bottleneck is usually not access but interpretation: most primary care visits do not have the time to walk through 14 days of CGM data and design a meaningful response. A direct primary care practice with time for that conversation makes CGMs much more useful.

What is the long-arc plan for someone using a CGM?

A 2-4 week diagnostic window, a structured review, a specific behavior change (timing, food choices, meal sequencing), and a re-check at 3-6 months with another short CGM window if useful. For most patients, this beats continuous use both in cost and in actionability.

Continuous Glucose Monitor (CGM) in Philadelphia, PA

TL;DR30-second take

Continuous glucose monitors (CGMs) measure interstitial glucose every few minutes and stream the data to your phone. They are well-established for type 1 and insulin-using type 2 diabetes; the longevity and metabolic-health use in non-diabetic adults is newer and best deployed as a short diagnostic window (2-4 weeks) rather than continuous lifetime use. Available in Philadelphia by prescription (Dexcom, FreeStyle Libre, Stelo) or over-the-counter (Lingo, Stelo Bio Sensor). Fishtown Medicine uses CGMs for short diagnostic windows in patients with prediabetes, insulin resistance, PCOS, or metabolic curiosity.

CGMs have become one of the most discussed tools in metabolic health. Some of the enthusiasm is earned: they catch dynamic glucose patterns that fasting glucose and HbA1c miss, they motivate behavior change, and they are clinically essential in insulin-using diabetes. Some of the enthusiasm is theater: the marketing of continuous lifetime CGM use to healthy adults outpaces the evidence that it changes outcomes.

This page is the honest middle: where CGMs help in Philadelphia, where they do not, and how Fishtown Medicine uses them.

What CGMs measure

CGMs measure interstitial glucose (the glucose in the fluid between cells) every 1-5 minutes via a sensor worn on the upper arm or abdomen. Sensors are typically replaced every 10-14 days. Data streams to a smartphone app, where you can see real-time glucose, daily patterns, and how specific meals affect you.

The data includes:

Time-in-range. What percentage of the time your glucose is in a target range (typically 70-180 for diabetes, often 70-140 or tighter for non-diabetic use).
Post-prandial peaks. How high glucose spikes after meals and how long it takes to come back down.
Overnight patterns. Sometimes catches sleep-related hypoglycemia or dawn-phenomenon hyperglycemia.
Glycemic variability. The standard deviation of glucose values; high variability correlates with worse metabolic outcomes.

CGMs in Philadelphia

Prescription CGMs: Dexcom G7, FreeStyle Libre 3, Medtronic systems. Available with prescription from any primary care practice. Insurance coverage is excellent for diabetes; for non-diabetic use, coverage varies.

Over-the-counter CGMs: Stelo (Dexcom) and Lingo (Abbott) are now available without prescription in 2026, designed for the non-diabetic metabolic health market. Approximately $89 for a 30-day sensor pack.

Local pharmacies (Walgreens, CVS, Rite Aid) typically stock at least one option. Mail-order pharmacy programs for diabetes-prescribed CGMs are also common.

When CGMs actually help (non-diabetic use)

The highest-value non-diabetic use cases:

Suspected insulin resistance or prediabetes with normal fasting glucose. A 2-4 week CGM window catches post-prandial spikes that standard testing misses.
PCOS or metabolic syndrome evaluation. The dynamic glucose pattern is more informative than fasting values.
Weight-loss plateau evaluation. CGMs sometimes reveal specific foods or eating windows that are stalling progress.
Patient motivation and behavior change. Seeing your glucose spike after specific foods often changes behavior more durably than verbal advice.
Suspected hypoglycemia or dawn phenomenon when standard testing is inconclusive.

When CGMs are less useful:

Asymptomatic metabolically healthy adults with normal HbA1c, normal fasting insulin, normal lipid panel, and no PCOS. Continuous data here is interesting but rarely changes clinical decisions.
Patients with disordered eating histories. CGMs can drive restrictive behavior in some patients.
Continuous lifetime use for healthy adults. A short diagnostic window followed by behavior change is usually sufficient.

Fishtown Medicine

A 90-minute conversation with Dr. Ash. A written plan you can actually follow.

Start your intake

How Fishtown Medicine uses CGMs

A 2-4 week diagnostic window is our default approach for non-diabetic patients. We typically order a single Dexcom or Libre sensor pack (or recommend a Stelo for self-purchase), have the patient wear it during a normal eating pattern, then meet to review the data together and design a behavior plan.

Patients who benefit from longer-term monitoring (active diabetes management, weight loss with CGM motivation, complex insulin resistance) get extended use.

For diabetes management, we follow standard practice: CGM is standard of care for type 1 and insulin-using type 2 diabetes.

What it costs

Membership at Fishtown Medicine covers all visits and ongoing management; see pricing for current rates. CGM interpretation and the behavior-change conversations are inside the membership. The sensors themselves are billed separately:

Diabetes with insurance coverage: copays typically $25-100/month.
Non-diabetic prescription use: insurance coverage variable.
Over-the-counter Stelo or Lingo: $89/month or similar.

Key Takeaways

CGMs are clinically essential for type 1 and insulin-using type 2 diabetes.
For non-diabetic adults, a 2-4 week diagnostic window is usually more useful than continuous use.
Over-the-counter options (Stelo, Lingo) make non-prescription access easier in 2026.
Fishtown Medicine uses CGMs strategically for the right patient at the right time.

Metabolic Health in Philadelphia
GLP-1 Weight Loss in Philadelphia
PCOS Care in Philadelphia
Metabolic Health Pillar
Direct Primary Care in Philadelphia
Advanced Lipid Testing - ApoB, Lp(a), and the panel beyond LDL
DEXA Scan - body composition and bone density measurement
VO2 Max Testing - the strongest single predictor of all-cause mortality

Fishtown Medicine | Services

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Start Your Intake

Frequently Asked Questions

Common Questions

Deep-Dive Questions

Ready when you are

Start your intake

Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.

TL;DR30-second take

This page is the honest middle: where CGMs help in Philadelphia, where they do not, and how Fishtown Medicine uses them.

What CGMs measure

The data includes:

Time-in-range. What percentage of the time your glucose is in a target range (typically 70-180 for diabetes, often 70-140 or tighter for non-diabetic use).
Post-prandial peaks. How high glucose spikes after meals and how long it takes to come back down.
Overnight patterns. Sometimes catches sleep-related hypoglycemia or dawn-phenomenon hyperglycemia.
Glycemic variability. The standard deviation of glucose values; high variability correlates with worse metabolic outcomes.

CGMs in Philadelphia

Local pharmacies (Walgreens, CVS, Rite Aid) typically stock at least one option. Mail-order pharmacy programs for diabetes-prescribed CGMs are also common.

When CGMs actually help (non-diabetic use)

The highest-value non-diabetic use cases:

Suspected insulin resistance or prediabetes with normal fasting glucose. A 2-4 week CGM window catches post-prandial spikes that standard testing misses.
PCOS or metabolic syndrome evaluation. The dynamic glucose pattern is more informative than fasting values.
Weight-loss plateau evaluation. CGMs sometimes reveal specific foods or eating windows that are stalling progress.
Patient motivation and behavior change. Seeing your glucose spike after specific foods often changes behavior more durably than verbal advice.
Suspected hypoglycemia or dawn phenomenon when standard testing is inconclusive.

When CGMs are less useful:

Asymptomatic metabolically healthy adults with normal HbA1c, normal fasting insulin, normal lipid panel, and no PCOS. Continuous data here is interesting but rarely changes clinical decisions.
Patients with disordered eating histories. CGMs can drive restrictive behavior in some patients.
Continuous lifetime use for healthy adults. A short diagnostic window followed by behavior change is usually sufficient.

Fishtown Medicine

A 90-minute conversation with Dr. Ash. A written plan you can actually follow.

Start your intake

How Fishtown Medicine uses CGMs

Patients who benefit from longer-term monitoring (active diabetes management, weight loss with CGM motivation, complex insulin resistance) get extended use.

For diabetes management, we follow standard practice: CGM is standard of care for type 1 and insulin-using type 2 diabetes.

What it costs

Diabetes with insurance coverage: copays typically $25-100/month.
Non-diabetic prescription use: insurance coverage variable.
Over-the-counter Stelo or Lingo: $89/month or similar.